Blog
RSS FeedPosted by Michael Wonder on 12 May 2022
After a 5 year fight to lower drug prices, Ottawa's pledge quietly falls apart
12 May 2022 - What began with a promise to protect Canadians ended with a commitment to support pharmaceutical companies. ...
Posted by Michael Wonder on 23 Jun 2021
Rare disease patient advocates continue battle for affordable drugs
23 June 2021 - Beth Vanstone, mother of local Cystic Fibrosis Warrior Madi Vanstone and director of the CF Get ...
Posted by Michael Wonder on 21 Jan 2021
Industry pooling helps maintain affordability of high cost drugs despite significant inflationary pressures
21 January 2021 - In 2019, the Canadian Drug Insurance Pooling Corporation's (CDIPC) high-cost drug sharing framework provided coverage to ...
Posted by Michael Wonder on 21 Dec 2020
Newly approved treatment could save a young child in Edmonton with a rare disease. It costs 2.8 million dollars per dose.
19 December 2020 - Reign Johnston is a happy baby who enjoys painting as much as playing with toys. His green ...
Posted by Michael Wonder on 10 Aug 2020
B.C. family nearing finish in race to raise $2.8 million to treat baby's rare disease
8 August 2020 - Parents hope funds will pay for expensive therapy not approved in Canada for type 1 spinal muscular ...
Posted by Michael Wonder on 20 Jun 2020
This drug can treat 90 per cent of cystic fibrosis patients, but it's not available in Canada
19 June 2020 - Struggling to breathe is one of the main symptoms of the novel coronavirus that has recently ...
Posted by Michael Wonder on 13 Feb 2020
The grass is the same colour, part II: prescription drug woes on both sides of the US-Canada border
13 February 2020 - Which industrialised nation with a fractured health care system and a divided government is having a high-stakes ...
Posted by Michael Wonder on 14 Jan 2020
Health insurance industry pooling mechanism makes high cost drugs accessible for record number of Canadians
14 January 2020 - The catastrophic expense of high cost drugs have been made affordable for a record number of ...
Posted by Michael Wonder on 17 Oct 2019
Canadian breakthrough that became the world's most expensive drug, then vanished, gets second chance
17 October 2019 - CBC story about how pharmaceutical industry abandoned gene therapy Glybera sparks NRC effort to re-invent it. ...
Posted by Michael Wonder on 01 Sep 2019
'Outrageously expensive': new drug approval will cost Ontario family 100K per year
30 August 2019 - Drug cost jumped from $5,000 to more than $100,000 per year. ...
Posted by Michael Wonder on 14 Aug 2019
Canadians benefitting from substantially lower generic drug prices
14 August 2019 - Latest agreement between public payers and the Canadian generic industry closes gap with international prices. ...
Posted by Michael Wonder on 20 Jul 2019
Biosimilar drugs a boon to be applauded as they provide equivalent treatment at – sometimes – half the price
19 July 2019 - The fastest-growing segment of our health-care system is prescription drugs – now constituting the second-highest category ...
Posted by Michael Wonder on 21 Mar 2019
Why Ontario parents could soon be paying more for prescription drugs
22 March 2019 - Some Ontario parents will be paying more for their kids’ medicine starting next month. Young adults ...
Posted by Michael Wonder on 18 Mar 2019
The impact of pharmaceutical rebates on patients’ drug expenditures
18 March 2019 - The drug-pricing landscape in Canada is complex, with 4 different agencies and each provincial, territorial and federal ...
Posted by Michael Wonder on 05 Feb 2019
Relief, but at what cost? The steep price of modern psoriasis medications
5 February 2019 - Biologics offer great relief to most, but hard to get coverage for. ...